human umbilical cord mesenchymal stem cells,Shanghai Life Science & Technology
- Generic Name
- human umbilical cord mesenchymal stem cells,Shanghai Life Science & Technology
Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Interstitial Lung Disease
Phase 1
Not yet recruiting
- Conditions
- Interstitial Lung Disease
- Interventions
- First Posted Date
- 2024-08-02
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Shanghai Life Science & Technology
- Target Recruit Count
- 24
- Registration Number
- NCT06534528
Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
Phase 1
Recruiting
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- First Posted Date
- 2022-07-21
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Shanghai Life Science & Technology
- Target Recruit Count
- 18
- Registration Number
- NCT05468502
- Locations
- 🇨🇳
Shanghai Sixth People's Hospital, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath